Multi-cycle chemotherapy
Showing 1 - 25 of >10,000
Early Predict Pathological Complete Response to Neoadjuvant
Recruiting
- Breast Cancer
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 8, 2022
Non-Myeloid Malignancy Trial in Beijing (YPEG-rhG-CSF, rhG-CSF/PEG-rhG-CSF)
Completed
- Non-Myeloid Malignancy
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2022
Chemo Induced Nausea and Vomiting Trial in Mount Olive (Akynzeo)
Recruiting
- Chemotherapy Induced Nausea and Vomiting
-
Mount Olive, AlabamaRudolph M Navari
Oct 8, 2023
Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)
Recruiting
- Nasopharyngeal Carcinoma
- Camrelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Mar 6, 2023
Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)
Not yet recruiting
- Pediatric Cancer
- +2 more
- Arsenic trioxide
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023
Chemo-induced Neuropathic Pain, Chemo-induced Peripheral Neuropathy Trial in Irvine, Port Charlotte, Singapore (Tetrodotoxin,
Recruiting
- Chemotherapy-induced Neuropathic Pain
- Chemotherapy-induced Peripheral Neuropathy
- Tetrodotoxin
- Placebo
-
Santa Rosa, California
- +2 more
Dec 2, 2022
Coronary Artery Disease Trial in Bucheon (Resting full-cycle ratio (RFR)-guided revascularization, Fractional flow ratio
Recruiting
- Coronary Artery Disease
- Resting full-cycle ratio (RFR)-guided revascularization
- Fractional flow ratio (FFR)-guided revascularization
-
Bucheon, Gyeonggi-do, Korea, Republic ofSejong general hospital, 91-121 Sosa 2-Dong, Sosa-Gu
Oct 3, 2023
Colorectal Cancer, Pancreatic Cancer Trial in Hangzhou (Bemalenograstim alfa)
Not yet recruiting
- Colorectal Cancer
- Pancreatic Cancer
- Bemalenograstim alfa
-
Hangzhou, Chinathe Second Affiliated Hospital of Medical College of Zhejiang Un
Nov 14, 2023
CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,
Active, not recruiting
- CNS Lymphoma
- +2 more
- Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
-
Basking Ridge, New Jersey
- +2 more
Jan 27, 2023
Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,
Not yet recruiting
- Breast Cancer Invasive
- +3 more
- Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
- Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023
Nasopharyngeal Carcinoma Trial in Shanghai (Radiotherapy, Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Jan 7, 2023
Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- 5-fu
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023
Pancreatic Cancer Trial in Dublin (Control, Intervention)
Not yet recruiting
- Pancreatic Cancer
- Control
- Intervention
-
Dublin, Leinster, IrelandSt Vincent's University Hospital
Nov 20, 2023
Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)
Recruiting
- Extensive Small Cell Lung Cancer
- Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
-
Jinan, Shan Dong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)
Recruiting
- Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
-
Canton, OhioGabrail Cancer and Research Center
Jul 25, 2023
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Rochester (Echocardiography, Electronic Health Record
Suspended
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Echocardiography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 10, 2023
Post Activation Potentiation Trial (Eccentric Exercise, Cycle ergometer)
Not yet recruiting
- Post Activation Potentiation
- Eccentric Exercise
- Cycle ergometer
- (no location specified)
Oct 28, 2022
Breast Cancer Female Trial in Shanghai (MW05, PEG-rhG-CSF)
Completed
- Breast Cancer Female
-
Shanghai, ChinaFudan University Affiliated Cancer Hospital
Dec 1, 2022
Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab plus TP, TP)
Not yet recruiting
- Oral Squamous Cell Carcinoma
- Camrelizumab plus TP
- TP
-
Wuhan, Hubei, ChinaHospital of Stomatology, Wuhan University
Mar 22, 2023
Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)
Not yet recruiting
- Breast Neoplasms
- Trilaciclib
- +7 more
-
Guangzhou, Gangdong, ChinaSun-yat sen university cancer center
Jul 30, 2023
Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- Intensity Modulated Radiation Therapy
- +3 more
- (no location specified)
Jul 11, 2023
Pregnancy Related, Pre-Eclampsia Trial in United States (Modified natural cycle, Programmed cycle)
Recruiting
- Pregnancy Related
- Pre-Eclampsia
- Modified natural cycle
- Programmed cycle
-
Sunnyvale, California
- +8 more
Aug 2, 2022
Hepatocellular Carcinoma Trial in Nanjing, Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)
Not yet recruiting
- Hepatocellular Carcinoma
- QL1706
- +4 more
-
Nanjing, Jiangsu, China
- +1 more
Jul 28, 2023
Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
- (no location specified)
Oct 25, 2023